KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)

Q: What does CUSIP 483497103 represent in this 13F holders report?

CUSIP 483497103 is the security identifier for KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in Q1 2024?

128 institutional investors reported KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share for Q1 2024. Use the holders table for investor-level position and value details.

CUSIP: 483497103

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 50,580,036
Total 13F shares: 46,978,393
Share change: +9,986,575
Total reported value: $557,162,578
Put/Call ratio: 114%
Price per share: $11.86
Number of holders: 128
Value change: +$117,921,974
Number of buys: 77
Number of sells: 47

Quarterly Holders Quick Answers

What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 483497103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VR Adviser, LLC	13F	Company	8.1%	4,092,731	$50,135,955	—	31 Dec 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	7.2%	3,622,294	$44,373,102	—	31 Dec 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	6.8%	3,440,345	$42,144,226	—	31 Dec 2023	13F
TCG Crossover Management, LLC	13F	Company	6.7%	3,395,495	$41,594,814	—	31 Dec 2023	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	5.3%	2,684,005	$32,879,061	—	31 Dec 2023	13F
BlackRock Finance, Inc.	13F	Company	4.4%	2,242,025	$27,464,808	—	31 Dec 2023	13F
Saturn V Capital Management LP	13F	Company	3.6%	1,807,563	$22,142,647	—	31 Dec 2023	13F
VANGUARD GROUP INC	13F	Company	3.5%	1,781,419	$21,822,382	—	31 Dec 2023	13F
Boxer Capital, LLC	13F	Company	3.3%	1,650,000	$20,212,500	—	31 Dec 2023	13F
Jefferies Financial Group Inc.	13F	Company	2.1%	1,080,000	$13,230,000	—	31 Dec 2023	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	2%	1,028,568	$12,599,958	—	31 Dec 2023	13F
Vivo Capital, LLC	13F	Company	1.7%	856,008	$10,486,098	—	31 Dec 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.5%	783,698	$9,600,301	—	31 Dec 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.4%	716,964	$8,782,547	—	31 Dec 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.4%	705,000	$8,636,250	—	31 Dec 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	630,048	$7,718,800	—	31 Dec 2023	13F
DAFNA Capital Management LLC	13F	Company	1.2%	601,032	$7,362,642	—	31 Dec 2023	13F
STATE STREET CORP	13F	Company	1.1%	537,102	$6,579,500	—	31 Dec 2023	13F
MORGAN STANLEY	13F	Company	0.89%	452,434	$5,542,317	—	31 Dec 2023	13F
STEMPOINT CAPITAL LP	13F	Company	0.84%	423,174	$5,183,882	—	31 Dec 2023	13F
Thomas Andrew Crockett	3/4/5	CEO, Director	— mixed-class rows	322,315 mixed-class rows	$4,648,801	—	17 Feb 2024	3/4/5
Woodline Partners LP	13F	Company	0.69%	346,863	$4,249,072	—	31 Dec 2023	13F
NORTHERN TRUST CORP	13F	Company	0.65%	326,496	$3,999,577	—	31 Dec 2023	13F
Nan Fung Group Holdings Ltd	13F	Company	0.6%	304,277	$3,727,393	—	31 Dec 2023	13F
Rosalind Advisors, Inc.	13F	Company	0.59%	300,000	$3,675,000	—	31 Dec 2023	13F
CITIGROUP INC	13F	Company	0.56%	281,909	$3,453,386	—	31 Dec 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.4%	202,522	$2,480,895	—	31 Dec 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.33%	165,759	$2,030,548	—	31 Dec 2023	13F
Caption Management, LLC	13F	Company	0.33%	165,000	$2,021,250	—	31 Dec 2023	13F
Opaleye Management Inc.	13F	Company	0.3%	150,000	$1,837,500	—	31 Dec 2023	13F
SG Americas Securities, LLC	13F	Company	0.27%	137,817	$1,688,000	—	31 Dec 2023	13F
AlphaCentric Advisors LLC	13F	Company	0.27%	137,000	$1,678,250	—	31 Dec 2023	13F
Ghost Tree Capital, LLC	13F	Company	0.26%	130,036	$1,592,941	—	31 Dec 2023	13F
Affinity Asset Advisors, LLC	13F	Company	0.25%	125,969	$1,543,120	—	31 Dec 2023	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.22%	111,734	$1,368,742	—	31 Dec 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.22%	110,922	$1,358,795	—	31 Dec 2023	13F
Bank of New York Mellon Corp	13F	Company	0.2%	100,693	$1,233,490	—	31 Dec 2023	13F
Walleye Capital LLC	13F	Company	0.19%	97,830	$1,198,418	—	31 Dec 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.18%	88,763	$1,087,347	—	31 Dec 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.17%	87,099	$1,066,963	—	31 Dec 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.16%	80,451	$985,525	—	31 Dec 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.14%	71,067	$870,572	—	31 Dec 2023	13F
Atom Investors LP	13F	Company	0.14%	69,844	$855,589	—	31 Dec 2023	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.1%	51,500	$630,875	—	31 Dec 2023	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.1%	51,100	$625,975	—	31 Dec 2023	13F
FMR LLC	13F	Company	0.1%	50,970	$624,382	—	31 Dec 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.09%	45,361	$555,667	—	31 Dec 2023	13F
BARCLAYS PLC	13F	Company	0.08%	42,531	$521,005	—	31 Dec 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.08%	42,300	$518,000	—	31 Dec 2023	13F
Campbell & CO Investment Adviser LLC	13F	Company	0.08%	41,365	$506,721	—	31 Dec 2023	13F

Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q1 2024

As of 31 Mar 2024, KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by 128 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,978,393 shares. The largest 10 holders included VR Adviser, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, Frazier Life Sciences Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., VANGUARD GROUP INC, Boxer Capital, LLC, Capital World Investors, and Saturn V Capital Management LP. This page lists 128 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

Q1 2024 holders

128

Holder diff

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.